Additionally, in melanoma patients who received adoptively transferred T cell therapy, tumor infiltrating lymphocytes (TILs) identified as recognizing candidate mutated peptides, as predicted by whole-exome sequencing and a major histocompatibility complex (MHC)-binding algorithm, were associated with tumor regression [40]. This evidence concerns the gene HLA-C and neoplasm.